CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Hormone Replacement Therapy

Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. 📎

Written by CYBERMED LIFE NEWS
Attachments:
Download this file (Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients..pdf)Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients..pdf[Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients.]342 kB
facebook Share on Facebook
Abstract Title:

Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients.

Abstract Source:

Reprod Biol Endocrinol. 2011;9:26. Epub 2011 Feb 18. PMID: 21332999

Abstract Author(s):

Anna Maria Aloisi, Ilaria Ceccarelli, Maria Carlucci, Annalisa Suman, Gianfranco Sindaco, Sergio Mameli, Valentina Paci, Laura Ravaioli, Giandomenico Passavanti, Valeria Bachiocco, Gilberto Pari

Article Affiliation:

Department of Physiology, Section of Neuroscience and Applied Physiology, University of Siena, Siena, Italy. This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract:

BACKGROUND: In male patients suffering from chronic pain, opioid administration induces severe hypogonadism, leading to impaired physical and psychological conditions such as fatigue, anaemia and depression. Hormone replacement therapy is rarely considered for these hypogonadic patients, notwithstanding the various pharmacological solutions available.

METHODS: To treat hypogonadism and to evaluate the consequent endocrine, physical and psychological changes in male chronic pain patients treated with morphine (epidural route), we tested the administration of testosterone via a gel formulation for one year. Hormonal (total testosterone, estradiol, free testosterone, DHT, cortisol), pain (VAS and other pain questionnaires), andrological (Ageing Males' Symptoms Scale-AMS) and psychological (POMS, CES-D and SF-36) parameters were evaluated at baseline (T0) and after 3, 6 and 12 months (T3, T6, T12 respectively).

RESULTS: The daily administration of testosterone increased total and free testosterone and DHT at T3, and the levels remained high until T12. Pain rating indexes (QUID) progressively improved from T3 to T12 while the other pain parameters (VAS, Area%) remained unchanged. The AMS sexual dimension and SF-36 Mental Index displayed a significant improvement over time.

CONCLUSIONS: In conclusion, our results suggest that a constant, long-term supply of testosterone can induce a general improvement of the male chronic pain patient's quality of life, an important clinical aspect of pain management.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.